Skip to main content

2011 Archived News

December
November
October
September
August
July
June
May
April
March
February
January

December

Weaving cotton transistors for wearable computing

One of the most fascinating bits of research in this area is being done by a group at Cornell University's Textiles Nanotechnology Laboratory. They've developed a means of actually making transistors out of cotton fibers to develop a type of organic electronics.

No more blind mice? Prosthetic device sends images directly to brain - and could help humans

Blind mice could be a thing of the past thanks to a new prosthetic device that's been tested on the animals.

Cornell-developed safety software goes national

Cornell generates some 50 tons of hazardous waste a year across its 6,500 research spaces, 100 departments and 85 buildings. Keeping tabs on all those spaces and waste products used to be a logistical nightmare for Cornell's Environmental Health and Safety (EH&S) crew.

Chuck Feeney '56 and The Atlantic Philanthropies identified as NYC Tech Campus donor

The Atlantic Philanthropies and its founding chairman, Chuck Feeney '56, were behind the $350 million gift -- initially announced as from an anonymous donor -- made in support of Cornell's New York City Tech Campus.

Cornell alumnus is behind $350 million gift to build science school in city

The donor whose $350 million gift will be critical in building Cornell University's new high-tech graduate school on Roosevelt Island is Atlantic Philanthropies, whose founder, Charles F. Feeney, is a Cornell alumnus who made billions of dollars through the Duty Free Shoppers Group.

Cornell wins $100 million bid to build campus on Roosevelt Island

Mayor Michael Bloomberg will announce Monday Cornell University the winner of a $100 million competition to build a state-of-the art engineering and applied science graduate school on Roosevelt Island, sources said.

Cornell wins contest for city tech campus

Mayor Michael Bloomberg plans to announce on Monday that Cornell University won the high-profile competition to build a new applied-science campus in New York City.

Four faculty members elected AAAS fellows

Four Cornell faculty members have been elected fellows of the American Association for the Advancement of Science (AAAS), the world's largest general scientific society and publisher of the journal Science.

Cornell given $350 million for New York City campus as Stanford withdraws

Cornell University announced an anonymous $350 million gift to support its bid for a proposed engineering campus in New York City hours after Stanford University said it was pulling out of the competition.

Fast-growing e2e Materials opening major manufacturing facility in Geneva, NY

Cornell startup, e2e Materials, developer of biocomposite materials ramping up manufacturing capacity to meet growing demand from Fortune 100 customers

New 'Herriot' strawberry: tough plant, tasty fruit

With high yields, good disease resistance, eye-appeal and a mild flavor with pineapple overtones, 'Herriot' is a sweet option for growers.

Artificial intestine to treat youths' bowel disorder

A tiny 3-D collagen 'scaffold' developed in a Cornell lab could prove a lifesaver for those who have lost parts of their intestine.

Cornell-developed safety software goes national as new startup

The product has potential in such markets as hospitals, pharmaceuticals, food services and other research-based organizations.

Tumor-targeting compound points the way to new personalized cancer treatments

New research reports on new method that reveals complete set of aberrant signaling pathways that give rise to cancers

Back to Top

November

Metabolon announces accreditation by College of American Pathologists

Cornell startup, Metabolon, Inc., announced that they have received laboratory accreditation from the College of American Pathologists (CAP).

New Diagnostic Test May Help Answer the Question 'Is My Mole a Melanoma?'

Researchers From Weill Cornell Medical College Report That the New Technique Is Greater Than 90 Percent Sensitive in Identifying Melanoma, the Deadliest Form of Skin Cancer

New method found to treat deadly prostate cancer

Weill Cornell researchers have established a new means of treating neuroendocrine prostate cancers, the most lethal subtype of the disease.

Canine patient simulators prepare veterinary students for emergencies

A high-tech stuffed robot dog is helping veterinary students at Cornell practice critical care procedures under nearly real-life conditions.

Apples with catchy names may boost revenue for farmers

Researchers at Cornell tested participants' willingness to pay for different apple varieties using auctions.

Researchers discover Achilles' heel in lethal form of prostate cancer

Weill Cornell researchers have discovered a genetic Achilles' heel in an aggressive type of prostate cancer.

Catchy names for apples may boost revenue

Using auctions, Cornell researchers tested participants' willingness to pay for different varieties of apples, including a patented variety developed at Cornell, currently named NY1.

Graphene to propel mechanical device technology forward

Cornell researcher, Harold Craighead, and his colleagues review the future of graphene.

Cornell developing Intel-funded cell phone-based stress monitor

Cornell researcher, Tanzeem Choudhury, and his colleagues are working on cell phones that can monitor stress levels in speech.

Chemically assembled metamaterials could lead to superlenses and cloaking

Cornell inventor, Uli Wiesner, and his colleagues have created metamaterials with unusual optical properties.

Cornell University receives NSF grant for research on graphene

Cornell inventor, Will Dichtel, will work on accurate design and synthesis of nanoribbons using controlled chemistry procedures.

Back to Top

October

Glow in the dark tumors that blind rats can now see

Sheila Nirenberg of Weill Cornell Medical College presented her lab's success allowing blind mice to essentially see again at TEDMED.

Researchers create transistors from natural cotton fibers

Cornell inventor, Juan Hinestroza, was part of an international team that developed transistors using natural cotton fibers.

Lung regeneration closer to reality with new discovery

Weill Cornell Medical College researchers take an important step forward in their quest to 'turn on' lung regeneration

PacBio posts Q3 revenues of $10.5M

Cornell startup, Pacific Biosciences, reports Q3 revenues of $10.5M.

Imaging scope may lead to fewer biopsies

Cornell researchers are developing prototypes of multiphoton endoscopes that can be used in clinical settings to directly image tissues or tumors.

Cornell researchers looking for more cold weather hardy grapes

Cornell researchers are focusing on developing grapes with three attributes - fruit quality, cold hardiness, and resistance to powdery mildew.

Metabolon and Shanghai Jiao Tong University open metabolomics lab in China

Cornell startup, Metabolon, opens a new metabolics lab in Shanghai, China in collaboration with Shanghai Jiao Tong University (SJTU).

Stealth Peptides moves mitochondrial candidate into Phase II trials

Cornell startup, Stealth Peptides, moves mitochondrial candidate into Phase II Trials.

John Alexander named Cornell Entrepreneur of the Year 2012

John Alexander '74, MBA '76, a founder of the CBORD Group, Inc., has been named Cornell Entrepreneur of the Year 2012.

Back to Top

September

NSF-funded project to test cloud computing for smart grid

A team of Cornell researchers is exploring the computational aspects of how to manage the changing electrical grid.

Cornell plant breeder engineers black-and-white cucumbers, pear-flavored melons

Cornell breeder, Michael Mazourek, is engineering organic varieties in his lab and fields, using a combination of traditional and cutting-edge techniques.

Cornell and UPenn researchers collaborate to find gene responsible for a disease that afflicts dogs

Cornell researchers, along with UPenn scientists, have identified a gene responsible for a blindness-inducing disease that afflicts dogs.

Cornell breeder develops new raspberry variety

Cornell professor, Courtney Weber, picked the first harvest of his newly-developed Crimson Giant Raspberry variety.

Cornell raspberry variety extends harvest into November

Cornell's new raspberry variety, Crimson Giant, can extend the harvest window for fresh, local raspberries to the beginning of November.

Finding may permit drug delivery to the brain - for Alzheimer's, multiple sclerosis and brain cancers

Cornell researcher, Margaret Bynoe, and her colleagues have found that when adenosine receptors are activated on cells that comprise the blood-brain barrier, a gateway into the blood-brain barrier can be established.

Cornell, Biotime to commercialize vascular cells derived from HESCs

Cornell signed an agreement with Biotime to develop and commercialize technology developed at Weill Cornell Medical College.

Cornell apples ripen easily and store well

Cornell apples, NY 1 and NY 2, are mentioned in an article about how breeders are creating odd, new hybrids.

Cornell developed variety wins Best of Show

Cornell developed variety, Flutterby Grande Peach Cobbler Nectar Bush, wins Best of Show at the 2011 Farwest Show.

Back to Top

August

Cornell researchers study fake reviews

Cornell researchers are tackling deceptive opinion spam.

Cornell Vice Provost emceed China Medical City event in New York City

Cornell Vice Provost, Alan Paau, emceed China Medical City event in New York City.

Cornell inventor recognized as a top tech innovator

Noah Snavely, Assistant Professor of Computer Science, has been named one of Technology Review Magazine's, 'TR35', a top technology innovator under age 35.

Cornell researchers explore fabric technology

Antibacterial clothing and anti-counterfeit devices are key pieces of research at Juan Hinestroza's Textiles Nanotechnology Laboratory.

Cornell researchers develop spectrum of fluorescent tags for monitoring RNA production and movement

Scientists at Weill Cornell Medical College have developed the means to tag RNA with fluorophores that allows the nucleic acid molecules to be tracked as they travel through living cells.

Back, neck pain sufferers could find relief with Cornell-developed spinal disc implants

Cornell engineers create a biologically based spinal implant that could mean relief for sufferers.

Back to Top

July

Shining light (literally) on the workings of cells

Samie Jaffrey of Weill Cornell Medical College and his colleagues have found a way to reveal what's happening inside a cell by attaching a reflective tag to a chemical called RNA.

Next Generation: World's Smallest Camera

Cornell researchers have invented a tiny camera with no lenses or moving parts. It is made of 4,000 light sensors.

Alleged theft of proprietary Cornell apples reported

Alleged theft of proprietary Cornell apples reported.

CCTEC partners with Kirchner Food Security Group

CCTEC partners with Kirchner Food Security Group, a group that was formed to tackle the growing issues and pursuing global opportunities of global food security.

3-D printing enters new era with standard file format

Cornell inventor Hod Lipson and his group develop a newly approved standard for 3-D printing file interchange that will greatly enhance 3-D printing capabilities.

Cornell inventor is named one of eight Microsoft Research Faculty fellows for 2011

Noah Snavely of Computer Science has been named a Microsoft Research Faculty Fellow for 2011.

New method defibrillates heart with less electricity and pain

Cornell scientists have developed a new and less painful method to end life-threatening heart fibrillations.

Cornell-developed camera could revolutionize science from surgery to robotics

Cornell inventor Alyosha Molnar and his colleagues develop a microscopic device that fits on the head of a pin, contains no lenses or moving parts, and costs pennies to make.

Cornell researchers develop lens-free, pinhead-size camera

Cornell researchers develop a lens-free camera that is 100th of a millimeter thick and one-half millimeter on each side.

Artificial tissue helps healthy skin grow

Cornell researchers have shown that tissue grafts that promote vascular growth could hasten wound healing.

Back to Top

June

CCTEC licensee actively planning for the managed release of new Cornell apples

New York Apple Growers (NYAG) is planning for the managed release of new Cornell apples.

BearClaw offers a lightweight, safer option for football drills

Cornell startup, MADathletic, is selling the football training device to university football programs, as well as, to high school and Pop warner teams.

Mayo Clinic licensing genetic test technology from Rheonix

Mayo Clinic is licensing a genotyping test for warfarin sensitivity in clinical and research settings from Cornell startup, Rheonix.

New Lyme disease test for horses and dogs will help improve treatment

Cornell researcher, Bettina Wagner, and her colleagues have developed a new test for Lyme disease that exceeds its predecessors in accuracy, specificity, and analytical sensitivity.

WCMC-Q researchers discover key for identifying gender in date palm trees

WCMC-Q researcher Joel Malek and his colleagues have identified a region of the date palm genome linked to gender.

Cornell startup provides portable ultrasound therapy for horses

Cornell startup, ZetrOZ, introduces the first wearable, therapeutic ultrasound system for the equine market, the UltrOZ Elite Therapy System.

Cornell listed among 14 top universities worldwide for patent success

A recent report issued by the Intellectual Property Owners Association listed 14 universities, including Cornell, among the top 300 organizations to receive patents from the USPTO in 2010.

Back to Top

May

Cornell startup expands business

Cornell startup, Metabolon, expands beyond service offering and adds diagnostics to business.

Weill Cornell researcher wins BioAccelerate Competition

Weill Cornell researcher, Sheila Nirenberg, wins $250,000 in the 2011 BioAccelerate competition.

CCTEC connects startups to Johnson School students

The Johnson School has proven to be a great resource for CCTEC to tap into when searching for business people (see page 5).

Weill Cornell investigative drug shuts down aggressive form of leukemia

Weill Cornell researchers have been able to overcome resistance of a form of leukemia to targeted therapy.

Empire State apple growers start managed variety group

Cornell startup, New York Apple Growers (NYAG), is seeking partners to market their new varieties.

Louis Walcer named director of McGovern Venture Development Center

Alumnus Louis Walcer named first director of the McGovern Family Center for Venture Development in the Life Sciences.

Cornell researchers develop portable test to detect deadly virus

A team of Cornell researchers is developing a portable, rapid and inexpensive test to detect rotavirus (a common cause of diarrhea), which would allow for the early intervention needed to save lives.

Cornell inventors elected to National Academy of Sciences

Paul McEuen, Dept. of Physics, and Carl Nathan, Dept. of Microbiology & Immunology, are elected to National Academy of Sciences.

Quest for vaccines to treat addiction

Recent results from a test of an anticocaine vaccine in mice at Weill Cornell Medical College were encouraging.

Cornell Dots or C Dots may greatly improve the diagnosis and treatment of cancer

C Dots were recently approved for clinical trials and are revolutionizing human optical capability.

Back to Top

April

3-D printers may someday allow labs to create replacement human organs

Cornell researchers are printing vertebral tissue that tests well in mice and working on printing heart valves.

Hazel Szeto of Weill Cornell Medical College is pioneering tiny compounds with big potential

Hazel Szeto's research could lead to a new class of drugs to treat conditions ranging from heart attacks and strokes, to diabetes and neurodegenerative diseases.

ADispell wins third prize in Cornell Venture Challenge

Competing entrepreneurs demonstrated unprecedented passion and talent at annual event, and showcased what it takes to sell an idea in the 21st century economy.

New Cornell corn available for nationwide sale

Bred to thrive in Northeast growing conditions, organic farmers across the United States can now plant the hardy hybrid; one of the first licenses was granted to Iowa-based Blue River Hybrids, which distributes organic seeds nationwide.

Cornell researchers release two better potato varieties for chips

Cornell University is releasing two brand new varieties of potatoes that have taken about 13 years to develop.

Cornell fiber scientists developing gas-trapping fabric

A new fabric that can selectively trap gases is being developed at Cornell, in a breakthrough that promises to help protect soldiers and first responders from exposure to toxic chemicals.

Cornell inventors develop clothes that can trap poisonous gas

A new cloth that can selectively trap noxious gases and odors has been developed by Cornell researchers.

Molecular frameworks show potential for better solar cells

Cornell inventor William Dichtel and colleagues have found a way to synthesize ordered organic films that could be a major step toward improving the performance of organic solar cells.

Cornell researcher explains how hosts fight infections without killing off 'friendly' bacteria

Cornell researcher Brian Lazzaro argues that clues from insect immunity suggest that previous models may not be mutually exclusive and, in fact, may work in tandem to trigger appropriately calibrated immune responses.

Back to Top

March

Bariatric surgery reduces long-term cardiovascular risk in diabetes patients

Bariatric (weight loss) surgery has been shown to reduce the risk of heart attack and stroke in patients with diabetes in a study done by Weill Cornell Medical College researchers.

Industry and tech transfer office collaborations rise

Industry collaborations among academic tech transfer offices rise as spinouts become more difficult in tepid VC/PE environment.

New technology for diagnosing keratitis in the equine eye

According to a Cornell inventor, a technology commonly used in human medicine would provide veterinarians with a quick, noninvasive alternative for diagnosing fungal keratitis in the equine eye.

Cornell inventor publishes fiction book

Cornell inventor, Paul McEuen, publishes a fiction book about a Cornell professor trying to contain a deadly strain of fungus weaponized by the Japanese during WWII.

Alzheimer's Drug Discovery Foundation (ADDF) supports Cornell startup Adispell

ADDF awards a grant of $170,750 to ADispell to develop small molecule drugs designed to halt the progression of cognition loss that occurs with Alzheimer's disease.

Alan Paau, Vice Provost & Executive Director of Technology Transfer & Economic Development, says 'Do not change 30-year-old Bayh-Dole jobs-engine law'

Since 1980 in particular, with the implementation of the Bayh-Dole Act, innovation has had a direct boost from the U.S. government by providing universities, small businesses and nonprofits with direct control of intellectual property resulting from federal funding.

Neurologix's gene therapy shows Parkinson's promise

Neurologix's (a Cornell licensee) gene therapy eased some Parkinson's disease symptoms in a mid-stage trial.

Terahertz chips could make portable scanners for medicine

Cornell inventors Ehsan Afshari and Omeed Momeni, Electrical & Computer Engineering, design microchips that generate terahertz radiation for medical, dental, and security applications.

Cornell professor invents new silent wind harvest to power cities

Prof. Frank Moon, Mechanical & Aerospace Engineering, developed a new method of harvesting wind energy that uses silent vibrational pads to transform wind-induced vibrations into electricity.

Back to Top

February

Brain imaging provides window into consciousness

Researchers at Weill Cornell Medical College use a sophisticated imaging test to probe for higher-level cognitive functioning in severely brain-injured patients.

Robots that reflect their own thoughts

Cornell inventors have developed robots that can reflect their own thoughts rather than model their own bodies.

Cornell researchers use a 3D printer to create a human ear made of silicone

Cornell researchers have developed a printer that can print with biological materials to make 3D tissue constructs.

Scientists devise artificial intestine to help engineer disease-fighting gut bacteria

Cornell inventor John March and his research team have developed an artificial intestine that will allow scientists to grow cells under realistic physiological conditions.

Cornell releases two new potato varieties, ideal for chip

Waneta and Lamoka are especially appealing to potato chip manufacturers because they fare well in storage and produce a nice color when cut.

Two Cornell startups are listed among Technology Review's 50 Most Innovative Companies of 2011

PacBio and Novomer, both startups based on licensed Cornell technologies, are listed in Technology Review's 50 Most Innovative Companies of 2011.

Sweeping view of prostate cancer genome yields deep insights

Using whole genome sequencing and multiple tumor samples, Weill Cornell researchers uncover genes tied to prostate cancer growth.

Cornell engineers unveil particle accelerator on a chip

Zipping ions down a MEMS racetrack could lead to portable particle beams.

Back to Top

January

Cornell inventor receives award to work in Germany for eight months

Johannes Gehrke of the Computer Science Department has received an award to support a collaborative research project in Germany.

Cornell Dots' that light up cancer cells go into clinical trials

The U.S. Food and Drug Administration has approved the first clinical trial in humans of 'Cornell Dots'.

Cornell faculty receive awards from NSF

Five Cornell faculty receive NSF CAREER awards.

Cornell scientists advance research of lethal Listeria

Cornell researchers are developing more effective ways to detect and prevent food-borne illness.

Boston Scientific acquires Cornell startup

Boston Scientific Corporation has acquired Cornell startup, Intelect Medical, Inc., for $78M.

New use for cold virus: an anti-cocaine vaccine

Cornell researchers, along with scientists at The Scripps Research Institute, have developed a vaccine that combines the common cold virus with a cocaine antigen to produce a long-lasting immunity to the stimulant effects of cocaine in mice.

Back to Top